DiyaaElDin Ashour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
DiyaaElDin Ashour has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Gustavo Campos Ramos
Department of Internal Medicine I, University Hospital Würzburg
12 shared publications - Stefan Frantz
Medizinische Klinik und Poliklinik I, Universitätsklinikum Würzburg, Würzburg, Deutschland
6 shared publications - Encarnita Mariotti-Ferrandiz
Immunology, Immunopathology, Immunotherapy i3 Lab, INSERM UMRS-959, Sorbonne Université
5 shared publications - Antoine-Emmanuel Saliba
Helmholtz Institute for RNA-based Infection Research, Helmholtz Centre for Infection Research, Würzburg, Germany (T.K., A.-E.S.).
4 shared publications - Peter P. Rainer
Medizinische Universitat Graz
4 shared publications Tobias Krammer
Helmholtz Institute for RNA-based Infection Research, Helmholtz Centre for Infection Research, Würzburg, Germany (T.K., A.-E.S.).
4 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 139 (9)
Cytomegalovirus Latency Fuels Inflammation Following Myocardial Infarction
BACKGROUND: Epidemiological studies have consistently associated cytomegalovirus (CMV) seropositivity with adverse cardiovascular outcomes. However, the mechanisms by which cytomegalovirus infection impacts pathophysiology in the heart remain poorly understood. In this study, we sought to dissect how latent murine cytomegalovirus infection impacts cardiac immune cell dynamics at steady-state and during postmyocardial infarction (MI) repair. METHODS: Experimental MI studies were conducted in C57BL/6J mice previously infected with murine cytomegalovirus. In situ inflammatory responses were characterized by spectral flow cytometry, bulk and single-cell RNA/T-cell receptor (TCR) sequencing, whereas cardiac function was monitored by echocardiography and cardiac magnetic resonance imaging. Moreover, we retrospectively assessed the cytomegalovirus serostatus and associated T-cell expansions in a well-characterized patient cohort with longitudinal cardiac magnetic resonance imaging data available and performed bulk TCR sequencing on peripheral blood and myocardial samples to identify cytomegalovirus-specific TCRs. RESULTS: Our findings show that exposure to murine cytomegalovirus induces long-term changes in the cardiac transcriptional profile and alterations in various cardiac-resident immune cell populations, including the establishment of virus-specific memory CD8 + T-cell residency. Compared with infarcted controls, mice previously exposed to murine cytomegalovirus exhibited stronger inflammatory responses marked by increased CD8 + T-cell infiltration and worsened cardiac function following MI. These observations in mice were supported by data from patients with cytomegalovirus seropositive MI, who harbored cytomegalovirus-responsive T cells in the heart. CONCLUSIONS: Our findings demonstrate that latent cytomegalovirus infection leads to long-term changes in the cardiac microenvironment, which ultimately impair post-MI healing outcomes.
- 9 October 2026
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 139 (9)
Open AccessCytomegalovirus Latency Fuels Inflammation Following Myocardial Infarction
BACKGROUND: Epidemiological studies have consistently associated cytomegalovirus (CMV) seropositivity with adverse cardiovascular outcomes. However, the mechanisms by which cytomegalovirus infection impacts pathophysiology in the heart remain poorly understood. In this study, we sought to dissect how latent murine cytomegalovirus infection impacts cardiac immune cell dynamics at steady-state and during postmyocardial infarction (MI) repair. METHODS: Experimental MI studies were conducted in C57BL/6J mice previously infected with murine cytomegalovirus. In situ inflammatory responses were characterized by spectral flow cytometry, bulk and single-cell RNA/T-cell receptor (TCR) sequencing, whereas cardiac function was monitored by echocardiography and cardiac magnetic resonance imaging. Moreover, we retrospectively assessed the cytomegalovirus serostatus and associated T-cell expansions in a well-characterized patient cohort with longitudinal cardiac magnetic resonance imaging data available and performed bulk TCR sequencing on peripheral blood and myocardial samples to identify cytomegalovirus-specific TCRs. RESULTS: Our findings show that exposure to murine cytomegalovirus induces long-term changes in the cardiac transcriptional profile and alterations in various cardiac-resident immune cell populations, including the establishment of virus-specific memory CD8 + T-cell residency. Compared with infarcted controls, mice previously exposed to murine cytomegalovirus exhibited stronger inflammatory responses marked by increased CD8 + T-cell infiltration and worsened cardiac function following MI. These observations in mice were supported by data from patients with cytomegalovirus seropositive MI, who harbored cytomegalovirus-responsive T cells in the heart. CONCLUSIONS: Our findings demonstrate that latent cytomegalovirus infection leads to long-term changes in the cardiac microenvironment, which ultimately impair post-MI healing outcomes.
- Open Access
- 16 July 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (29)
A human-specific long noncoding RNA regulator of antigen-presenting cell viability and antimicrobial defense
Macrophages are essential for both, to clear pathogens and preserve tissue homeostasis, yet the molecular regulators of this equilibrium remain incompletely defined. Here, we identify SAILR (survival associated immune-regulatory RNA), a primate-specific long noncoding RNA (lncRNA), as a critical modulator of macrophage viability under infection conditions. SAILR is induced during monocyte-to-macrophage differentiation, but rapidly downregulated upon bacterial challenge in a nuclear factor kappa B (NF-κB) dependent manner. In both naïve and immune-activated macrophages, SAILR dampens the expression of adhesion, phagocytosis, and invasion factors, which include SIGLEC1 and MMP7. During infection with Salmonella Typhimurium, depletion of SAILR sensitizes macrophages to apoptosis, resulting in loss of intracellular replication niches and reduced bacterial recovery. Conversely, enforced SAILR expression promotes macrophage survival and increases intracellular pathogen burden. Mechanistically, SAILR interacts with the antiapoptotic adaptor protein 14-3-3β to support macrophage survival. Notably, downregulation of SAILR is mirrored in circulating immune cells from patients with severe COVID-19 and sepsis. Together, our findings position SAILR as a central regulator in linking macrophage survival to host–pathogen interaction and disease pathophysiology.
- 16 July 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (29)
Open AccessA human-specific long noncoding RNA regulator of antigen-presenting cell viability and antimicrobial defense
Macrophages are essential for both, to clear pathogens and preserve tissue homeostasis, yet the molecular regulators of this equilibrium remain incompletely defined. Here, we identify SAILR (survival associated immune-regulatory RNA), a primate-specific long noncoding RNA (lncRNA), as a critical modulator of macrophage viability under infection conditions. SAILR is induced during monocyte-to-macrophage differentiation, but rapidly downregulated upon bacterial challenge in a nuclear factor kappa B (NF-κB) dependent manner. In both naïve and immune-activated macrophages, SAILR dampens the expression of adhesion, phagocytosis, and invasion factors, which include SIGLEC1 and MMP7. During infection with Salmonella Typhimurium, depletion of SAILR sensitizes macrophages to apoptosis, resulting in loss of intracellular replication niches and reduced bacterial recovery. Conversely, enforced SAILR expression promotes macrophage survival and increases intracellular pathogen burden. Mechanistically, SAILR interacts with the antiapoptotic adaptor protein 14-3-3β to support macrophage survival. Notably, downregulation of SAILR is mirrored in circulating immune cells from patients with severe COVID-19 and sepsis. Together, our findings position SAILR as a central regulator in linking macrophage survival to host–pathogen interaction and disease pathophysiology.
- Open Access
- 19 April 2026
- Published by Wiley in Immunological Reviews
- Vol. 339 (1) , e70125
T Cell Receptor Repertoires Across the Continuum of Vascular, Myocardial, and Age‐Related Diseases
Cardiovascular diseases (CVD) are shaped by a complex interplay with immune mechanisms. In particular, the distinct roles of antigen‐specific T cell mechanisms are emerging as critical determinants across a broad spectrum of conditions, ranging from atherosclerosis, myocardial infarction (MI), heart failure (HF), and myocarditis. Because these T cell responses are fundamentally driven by antigen recognition of cardiovascular antigens, understanding T cell clonal dynamics via accessing T cell receptor (TCR) repertoires might provide valuable mechanistic insights for developing targeted diagnostic and therapeutic immunomodulatory approaches in cardiology. In this review, we discuss T cell‐dependent mechanisms and TCR clonal dynamics across various CVD. Moreover, by curating public bulk and single‐cell TCR datasets across different etiologies, we present a first‐in‐class adaptive immune receptor database in cardiovascular diseases (CVD‐TCR database). The discussions and resources herein presented seek to promote an integrated understanding of tissue‐specific immune mechanisms across different CVD, facilitate the identification of shared clonotypes and motifs, and provide a framework for computational modeling of TCR repertoires across the CVD spectrum.
- 19 April 2026
- Published by Wiley in Immunological Reviews
- Vol. 339 (1) , e70125
Open AccessT Cell Receptor Repertoires Across the Continuum of Vascular, Myocardial, and Age‐Related Diseases
Cardiovascular diseases (CVD) are shaped by a complex interplay with immune mechanisms. In particular, the distinct roles of antigen‐specific T cell mechanisms are emerging as critical determinants across a broad spectrum of conditions, ranging from atherosclerosis, myocardial infarction (MI), heart failure (HF), and myocarditis. Because these T cell responses are fundamentally driven by antigen recognition of cardiovascular antigens, understanding T cell clonal dynamics via accessing T cell receptor (TCR) repertoires might provide valuable mechanistic insights for developing targeted diagnostic and therapeutic immunomodulatory approaches in cardiology. In this review, we discuss T cell‐dependent mechanisms and TCR clonal dynamics across various CVD. Moreover, by curating public bulk and single‐cell TCR datasets across different etiologies, we present a first‐in‐class adaptive immune receptor database in cardiovascular diseases (CVD‐TCR database). The discussions and resources herein presented seek to promote an integrated understanding of tissue‐specific immune mechanisms across different CVD, facilitate the identification of shared clonotypes and motifs, and provide a framework for computational modeling of TCR repertoires across the CVD spectrum.
- Open Access
Murine CMV infection unmasks macrophage-driven inflammatory cardiomyopathy in Pkp2 , but not in Ttn mutant mice
2. Background: Genetic cardiomyopathies display variable penetrance and phenotypic expression, highlighting the influence of environmental modulators. Myocarditis, commonly triggered by cardiotropic viruses, overlaps clinically with genetic cardiomyopathies. Consequently, these infections are implicated as secondary factors that accelerate disease onset and progression, yet their precise impact in specific genetic settings remains unexplored. Methods: To interrogate this, genetic mouse models heterozygous for a mutant allele of desmosomal plakophilin-2 ( Pkp2 +/− ) or sarcomeric titin ( Ttn +/− ), genes frequently linked to acute myocarditis, were challenged with murine cytomegalovirus (MCMV) to determine how latent infection influences myocardial inflammation, tissue remodeling, and cardiac performance. Integrated experimental approaches, including echocardiography, histology, flow cytometry, single-cell RNA sequencing, as well as cytokine and kinome analyses, defined immune and signaling responses in infected versus non-infected hearts. Results: Acute, MCMV-induced viral myocarditis and subsequent latent MCMV infection unmasked early disease onset in Pkp2 +/− animals, leading to progressive systolic impairment, whereas in Ttn +/− mice cardiac structure and function remained preserved throughout infection. Cardiac immune profiling uncovered infection- and genotype-specific divergence: both genetic models showed a stable myocardial effector-memory CD8 + T-cell response to MCMV, but only Pkp2 +/− hearts recruited additional Ly6C + CCR2 + monocytes and macrophages with distinct inflammatory signatures. In the absence of infection, Pkp2 insufficiency initiated subclinical CCL2 secretion and subsequent recruitment of CCR2 + cells, reflecting early immune activation preceding age-associated functional and structural decline. At this stage, cytokine and kinase evaluations indicated a balance between proinflammatory and compensatory signals. However, with aging or following MCMV challenge, this balance shifted towards persistent inflammation, evidenced by chronic upregulation of cytokines and activation of signaling pathways, which ultimately led to adverse effects and myocardial dysfunction. Conclusions: Manifestation of genetic cardiomyopathies depends on interactions between inherited susceptibility and environmental stressors. Here, we show that cytomegalovirus infection intensifies inflammation in PKP2 -related cardiomyopathy. In contrast, TTN -linked cardiomyopathy does not exhibit increased inflammation under the same conditions. For individuals carrying desmosomal variants, infection control and tailored anti-inflammatory strategies may attenuate or delay disease manifestation and progression.
Open AccessMurine CMV infection unmasks macrophage-driven inflammatory cardiomyopathy in Pkp2 , but not in Ttn mutant mice
2. Background: Genetic cardiomyopathies display variable penetrance and phenotypic expression, highlighting the influence of environmental modulators. Myocarditis, commonly triggered by cardiotropic viruses, overlaps clinically with genetic cardiomyopathies. Consequently, these infections are implicated as secondary factors that accelerate disease onset and progression, yet their precise impact in specific genetic settings remains unexplored. Methods: To interrogate this, genetic mouse models heterozygous for a mutant allele of desmosomal plakophilin-2 ( Pkp2 +/− ) or sarcomeric titin ( Ttn +/− ), genes frequently linked to acute myocarditis, were challenged with murine cytomegalovirus (MCMV) to determine how latent infection influences myocardial inflammation, tissue remodeling, and cardiac performance. Integrated experimental approaches, including echocardiography, histology, flow cytometry, single-cell RNA sequencing, as well as cytokine and kinome analyses, defined immune and signaling responses in infected versus non-infected hearts. Results: Acute, MCMV-induced viral myocarditis and subsequent latent MCMV infection unmasked early disease onset in Pkp2 +/− animals, leading to progressive systolic impairment, whereas in Ttn +/− mice cardiac structure and function remained preserved throughout infection. Cardiac immune profiling uncovered infection- and genotype-specific divergence: both genetic models showed a stable myocardial effector-memory CD8 + T-cell response to MCMV, but only Pkp2 +/− hearts recruited additional Ly6C + CCR2 + monocytes and macrophages with distinct inflammatory signatures. In the absence of infection, Pkp2 insufficiency initiated subclinical CCL2 secretion and subsequent recruitment of CCR2 + cells, reflecting early immune activation preceding age-associated functional and structural decline. At this stage, cytokine and kinase evaluations indicated a balance between proinflammatory and compensatory signals. However, with aging or following MCMV challenge, this balance shifted towards persistent inflammation, evidenced by chronic upregulation of cytokines and activation of signaling pathways, which ultimately led to adverse effects and myocardial dysfunction. Conclusions: Manifestation of genetic cardiomyopathies depends on interactions between inherited susceptibility and environmental stressors. Here, we show that cytomegalovirus infection intensifies inflammation in PKP2 -related cardiomyopathy. In contrast, TTN -linked cardiomyopathy does not exhibit increased inflammation under the same conditions. For individuals carrying desmosomal variants, infection control and tailored anti-inflammatory strategies may attenuate or delay disease manifestation and progression.
- Open Access
Cytomegalovirus latency exacerbates cardiac inflammation and tissue remodeling after myocardial infarction
Background: Epidemiological studies have consistently associated cytomegalovirus (CMV) seropositivity with adverse cardiovascular outcomes. However, the mechanisms by which CMV infection impacts pathophysiological mechanisms in the heart remain poorly understood. In this study, we sought to dissect how latent murine CMV infection impacts cardiac immune cell dynamics at steady-state and during post-myocardial infarction (MI) repair. Methods: Experimental MI studies were conducted in C57BL/6J mice previously infected with murine CMV (MCMV). In situ inflammatory responses were characterized by spectral flow cytometry, bulk and single-cell RNA / T cell receptor sequencing, whereas cardiac function was monitored by echocardiography and magnetic resonance imaging (cMRI). Moreover, we retrospectively assessed the CMV serostatus in a well-characterized patient cohort with longitudinal cMRI data available and performed bulk T cell receptor sequencing on peripheral blood and myocardial samples to identify CMV-specific TCRs. Results: Our findings show that exposure to MCMV induces long-term changes in the cardiac transcriptional profile and alterations in cardiac-resident immune cell populations, including the establishment of virus-specific memory CD8 + T cell residency. Compared to infarcted controls, mice previously exposed to MCMV exhibited stronger inflammatory responses, marked by increased CD8 + T cell infiltration, and worsened cardiac function following MI. These observations in mice were supported by data from CMV-seropositive MI patients, who harbored CMV-responsive T cells in the heart. Conclusions: Our findings demonstrate that latent CMV infection leads to long-term changes in the cardiac microenvironment, which ultimately impair post-MI healing outcomes.
Open AccessCytomegalovirus latency exacerbates cardiac inflammation and tissue remodeling after myocardial infarction
Background: Epidemiological studies have consistently associated cytomegalovirus (CMV) seropositivity with adverse cardiovascular outcomes. However, the mechanisms by which CMV infection impacts pathophysiological mechanisms in the heart remain poorly understood. In this study, we sought to dissect how latent murine CMV infection impacts cardiac immune cell dynamics at steady-state and during post-myocardial infarction (MI) repair. Methods: Experimental MI studies were conducted in C57BL/6J mice previously infected with murine CMV (MCMV). In situ inflammatory responses were characterized by spectral flow cytometry, bulk and single-cell RNA / T cell receptor sequencing, whereas cardiac function was monitored by echocardiography and magnetic resonance imaging (cMRI). Moreover, we retrospectively assessed the CMV serostatus in a well-characterized patient cohort with longitudinal cMRI data available and performed bulk T cell receptor sequencing on peripheral blood and myocardial samples to identify CMV-specific TCRs. Results: Our findings show that exposure to MCMV induces long-term changes in the cardiac transcriptional profile and alterations in cardiac-resident immune cell populations, including the establishment of virus-specific memory CD8 + T cell residency. Compared to infarcted controls, mice previously exposed to MCMV exhibited stronger inflammatory responses, marked by increased CD8 + T cell infiltration, and worsened cardiac function following MI. These observations in mice were supported by data from CMV-seropositive MI patients, who harbored CMV-responsive T cells in the heart. Conclusions: Our findings demonstrate that latent CMV infection leads to long-term changes in the cardiac microenvironment, which ultimately impair post-MI healing outcomes.
- Open Access
Interferon gamma signaling drives cardiac metabolic rewiring
Background: IFN-gamma (IFN-γ) signaling influences myocardial inflammation and fibrosis across a wide range of conditions, including ischemic and non-ischemic heart failure (HF). However, the direct effects of IFN-γ on cardiomyocytes remain poorly understood. Here, we developed a novel in vivo model to investigate how IFN-γ impacts myocardial metabolism and function. Methods: Male C57BL/6J mice were injected intravenously with hepatotropic adeno-associated virus (AAV2/8) carrying Ifng and nLuc reporter under the albumin promoter (AAV- Ifng ) or empty vector control virus (AAV - ctrl). Cardiac alterations were monitored on day 28 through flow cytometry, bulk RNA sequencing, targeted metabolomics, isolated mitochondrial activity, echocardiography, and in vivo imaging using [ 18 F]fluordeoxyglucose ([ 18 F]FDG) and [ 18 F]fluoro-6-thia-heptadecanoic acid. Additionally, mice lacking IFN-γ receptor expression in cardiomyocytes ( Myh6 Cre Ifngr1 fl/fl ) were used to further dissect the cell-intrinsic roles of IFN-γ signaling in cardiomyocyte metabolic reprograming. Results: After confirming liver-specific viral transfection and elevated serum IFN-γ production at physiological levels, we observed cardiac metabolic adaptation and rewiring in animals treated with AAV- Ifng compared to control animals. Myocardial bulk RNA sequencing and gene set enrichment analysis identified an IFN-γ response signature accompanied by marked down-regulations of oxidative phosphorylation and fatty acid oxidation pathways. Functional assessment of isolated cardiac mitochondria showed decreased oxygen consumption, and targeted metabolomics confirmed metabolic shifts toward glycolysis in mice overexpressing IFN-γ. In vivo imaging confirmed increased cardiac glucose uptake following AAV- Ifng treatment. Notably, these metabolic alterations were abrogated in mice with cardiomyocyte-specific deletion of IFN-γ receptors (IFNGR). Conclusions: Systemic IFN-γ induces pronounced metabolic reprogramming in the heart, characterized by increased glucose uptake and reduced oxidative phosphorylation, via direct signaling through cardiomyocyte IFNGR. These alterations mirror those observed in aging and some forms of HF, thereby highlighting that, beyond classical inflammation, this cytokine regulates cardiac metabolism. Novelty and significance: What is known?: Immunological mechanisms can impact myocardial disease progression through complex context-dependent mechanisms. IFN-γ, a cytokine primarily secreted by natural killer and T cells, promotes myocardial inflammation and fibrosis in the context of autoimmune myocarditis, pressure-overload-induced heart failure, and Chagas cardiomyopathy. Cytokines exert pleiotropic effects and can influence inflammatory responses through mechanisms involving control of energy metabolism. What new information does this article contribute?: A novel adeno-associated virus model of systemic IFN-γ elevation allows assessment of cardio-immune-metabolic crosstalk without confounding factors. IFN-γ drives cardiac metabolic reprogramming in inflammatory contexts, characterized by enhanced glucose uptake and glycolysis with mitochondrial dysfunction, ultimately altering cardiac metabolic fluxes and function. The IFN-γ-induced cardiac metabolic reprogramming is, at least in part, mediated through direct signaling via receptors on cardiomyocytes.
Open AccessInterferon gamma signaling drives cardiac metabolic rewiring
Background: IFN-gamma (IFN-γ) signaling influences myocardial inflammation and fibrosis across a wide range of conditions, including ischemic and non-ischemic heart failure (HF). However, the direct effects of IFN-γ on cardiomyocytes remain poorly understood. Here, we developed a novel in vivo model to investigate how IFN-γ impacts myocardial metabolism and function. Methods: Male C57BL/6J mice were injected intravenously with hepatotropic adeno-associated virus (AAV2/8) carrying Ifng and nLuc reporter under the albumin promoter (AAV- Ifng ) or empty vector control virus (AAV - ctrl). Cardiac alterations were monitored on day 28 through flow cytometry, bulk RNA sequencing, targeted metabolomics, isolated mitochondrial activity, echocardiography, and in vivo imaging using [ 18 F]fluordeoxyglucose ([ 18 F]FDG) and [ 18 F]fluoro-6-thia-heptadecanoic acid. Additionally, mice lacking IFN-γ receptor expression in cardiomyocytes ( Myh6 Cre Ifngr1 fl/fl ) were used to further dissect the cell-intrinsic roles of IFN-γ signaling in cardiomyocyte metabolic reprograming. Results: After confirming liver-specific viral transfection and elevated serum IFN-γ production at physiological levels, we observed cardiac metabolic adaptation and rewiring in animals treated with AAV- Ifng compared to control animals. Myocardial bulk RNA sequencing and gene set enrichment analysis identified an IFN-γ response signature accompanied by marked down-regulations of oxidative phosphorylation and fatty acid oxidation pathways. Functional assessment of isolated cardiac mitochondria showed decreased oxygen consumption, and targeted metabolomics confirmed metabolic shifts toward glycolysis in mice overexpressing IFN-γ. In vivo imaging confirmed increased cardiac glucose uptake following AAV- Ifng treatment. Notably, these metabolic alterations were abrogated in mice with cardiomyocyte-specific deletion of IFN-γ receptors (IFNGR). Conclusions: Systemic IFN-γ induces pronounced metabolic reprogramming in the heart, characterized by increased glucose uptake and reduced oxidative phosphorylation, via direct signaling through cardiomyocyte IFNGR. These alterations mirror those observed in aging and some forms of HF, thereby highlighting that, beyond classical inflammation, this cytokine regulates cardiac metabolism. Novelty and significance: What is known?: Immunological mechanisms can impact myocardial disease progression through complex context-dependent mechanisms. IFN-γ, a cytokine primarily secreted by natural killer and T cells, promotes myocardial inflammation and fibrosis in the context of autoimmune myocarditis, pressure-overload-induced heart failure, and Chagas cardiomyopathy. Cytokines exert pleiotropic effects and can influence inflammatory responses through mechanisms involving control of energy metabolism. What new information does this article contribute?: A novel adeno-associated virus model of systemic IFN-γ elevation allows assessment of cardio-immune-metabolic crosstalk without confounding factors. IFN-γ drives cardiac metabolic reprogramming in inflammatory contexts, characterized by enhanced glucose uptake and glycolysis with mitochondrial dysfunction, ultimately altering cardiac metabolic fluxes and function. The IFN-γ-induced cardiac metabolic reprogramming is, at least in part, mediated through direct signaling via receptors on cardiomyocytes.
- Open Access
Tracking antigen-specific T cell responses in patients with myocardial infarction
Antigen-specific T cells can impact myocardial diseases, but appropriate model antigens and tools to track specific cells in patients are still lacking. Herein, we sought to identify and functionally characterize specific TCRs recognizing an epitope derived from the human adrenergic receptor beta 1 (ADRB1) presented on HLA-DRB1*13. Peripheral mononuclear cells obtained from HLA-DRB1*13 + subjects were stimulated in vitro with ADRB1 167-182 peptide and the expanded CD4 + T cells expressing activation induced markers were sorted for single-cell RNA / TCR-sequencing. Downstream analysis revealed clonal expansion of ADRB1 167-182 -stimulated CD4 + T cells with a distinct TCR repertoire signature. Moreover, analysis of the TCRβ complementarity determining region 3 (CDR3) led to the identification of a distinct motif enriched in ADRB1 167-182 -stimulated IFN-γ-producing cells. Selected TCRs were expressed in reporter cell lines, and their antigen specificity was further assessed by specific HLA-tetramers and antigen stimulation. Moreover, immunophenotyping of peripheral blood cells from MI patients revealed that ADRB1-specific cells preferentially exhibited a memory phenotype. Taken together, our study provides annotation and functional validation of defined TCRs specific to an antigen relevant to human cardiovascular diseases, offering new tools to track antigen-specific cells in patients with myocardial disease.
Open AccessTracking antigen-specific T cell responses in patients with myocardial infarction
Antigen-specific T cells can impact myocardial diseases, but appropriate model antigens and tools to track specific cells in patients are still lacking. Herein, we sought to identify and functionally characterize specific TCRs recognizing an epitope derived from the human adrenergic receptor beta 1 (ADRB1) presented on HLA-DRB1*13. Peripheral mononuclear cells obtained from HLA-DRB1*13 + subjects were stimulated in vitro with ADRB1 167-182 peptide and the expanded CD4 + T cells expressing activation induced markers were sorted for single-cell RNA / TCR-sequencing. Downstream analysis revealed clonal expansion of ADRB1 167-182 -stimulated CD4 + T cells with a distinct TCR repertoire signature. Moreover, analysis of the TCRβ complementarity determining region 3 (CDR3) led to the identification of a distinct motif enriched in ADRB1 167-182 -stimulated IFN-γ-producing cells. Selected TCRs were expressed in reporter cell lines, and their antigen specificity was further assessed by specific HLA-tetramers and antigen stimulation. Moreover, immunophenotyping of peripheral blood cells from MI patients revealed that ADRB1-specific cells preferentially exhibited a memory phenotype. Taken together, our study provides annotation and functional validation of defined TCRs specific to an antigen relevant to human cardiovascular diseases, offering new tools to track antigen-specific cells in patients with myocardial disease.
- Open Access
- 4 March 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (5) , e038331
Illuminating Cardiac Remodeling: Insights From [ 18 F]‐Fluorodeoxyglucose Positron Emission Tomography Imaging in Plakoglobin‐Associated Arrhythmogenic Cardiomyopathy
Background: Arrhythmogenic cardiomyopathy (ACM) is a genetic heart muscle disease, which presents with arrhythmias and sudden cardiac death, along with progressive cardiac remodeling and myocardial inflammation. This study aims to elucidate the patterns of [ 18 F]‐fluorodeoxyglucose ([ 18 F]‐FDG) uptake in a mouse model of plakoglobin‐associated cardiac disease to better understand its diagnostic potential. Methods and Results: Plakoglobin ( Jup ) knockout mice developed a cardiomyopathy that presented an ACM‐like phenotype at 6 weeks of age. Flow cytometry experiments showed a significant increase of immune cells, for example, an expansion of proinflammatory and tissue‐injury macrophages. In vivo positron emission tomography and ex vivo autoradiography showed increased [ 18 F]‐FDG uptake in genotype positive hearts. A correlative analysis between [ 18 F]‐FDG positivity and macrophage infiltration using CD68 and CD206 staining did not show colocalization. CD68 and CD206 positivity was primarily observed within the fibrotic scar, whereas [ 18 F]‐FDG uptake was predominantly identified in CD68 and CD206‐negative tissue areas. Instead, [ 18 F]‐FDG signal seemed to originate from cardiomyocytes adjacent to areas of fibrotic remodeling. Morphometric analysis revealed hypertrophy of these cardiomyocytes, which may reflect metabolic remodeling as a compensatory response. Conclusions: In our murine model of Jup ‐related ACM, strong cardiac [ 18 F]‐FDG uptake was detected, which colocalized with regional hypertrophic cardiomyocytes rather than inflammatory cells. These findings indicate that [ 18 F]‐FDG positron emission tomography is a valuable tool for identifying and localizing hypermetabolic areas associated with cardiac remodeling in ACM, providing insights into disease mechanisms and potential diagnostic strategies.
- 4 March 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (5) , e038331
Open AccessIlluminating Cardiac Remodeling: Insights From [ 18 F]‐Fluorodeoxyglucose Positron Emission Tomography Imaging in Plakoglobin‐Associated Arrhythmogenic Cardiomyopathy
Background: Arrhythmogenic cardiomyopathy (ACM) is a genetic heart muscle disease, which presents with arrhythmias and sudden cardiac death, along with progressive cardiac remodeling and myocardial inflammation. This study aims to elucidate the patterns of [ 18 F]‐fluorodeoxyglucose ([ 18 F]‐FDG) uptake in a mouse model of plakoglobin‐associated cardiac disease to better understand its diagnostic potential. Methods and Results: Plakoglobin ( Jup ) knockout mice developed a cardiomyopathy that presented an ACM‐like phenotype at 6 weeks of age. Flow cytometry experiments showed a significant increase of immune cells, for example, an expansion of proinflammatory and tissue‐injury macrophages. In vivo positron emission tomography and ex vivo autoradiography showed increased [ 18 F]‐FDG uptake in genotype positive hearts. A correlative analysis between [ 18 F]‐FDG positivity and macrophage infiltration using CD68 and CD206 staining did not show colocalization. CD68 and CD206 positivity was primarily observed within the fibrotic scar, whereas [ 18 F]‐FDG uptake was predominantly identified in CD68 and CD206‐negative tissue areas. Instead, [ 18 F]‐FDG signal seemed to originate from cardiomyocytes adjacent to areas of fibrotic remodeling. Morphometric analysis revealed hypertrophy of these cardiomyocytes, which may reflect metabolic remodeling as a compensatory response. Conclusions: In our murine model of Jup ‐related ACM, strong cardiac [ 18 F]‐FDG uptake was detected, which colocalized with regional hypertrophic cardiomyocytes rather than inflammatory cells. These findings indicate that [ 18 F]‐FDG positron emission tomography is a valuable tool for identifying and localizing hypermetabolic areas associated with cardiac remodeling in ACM, providing insights into disease mechanisms and potential diagnostic strategies.
- Open Access
Identification of a novel myosin antigen activating CD8 + T cells in C57BL/6 mice
Summary: Heart-specific T cells play important roles in myocardial diseases, including myocarditis, myocardial infarction, and heart failure. However, only few cardiac antigens and their respective specific T cell receptors (TCRs) have been validated so far. Therefore, we sought to identify new cardiac T cell epitopes in C57BL/6 mice and to characterize the specific TCRs. Antigen mapping of myosin heavy chain alpha (MYHCA) led to the identification of a 9-mer epitope (MYHCA 724-732 ) recognized by CD8 + T cells. Single-cell TCR sequencing (scTCR-seq) analysis of MYHCA-stimulated CD8 + T cells enabled the identification of distinct TCRs enriched on specific T cells. Selected TCRs inferred from scTCR-seq data were then expressed on reporter cell lines and functionally validated. Our study expands the toolkit required to study heart-directed immune responses by revealing a new cardiac antigen and specific TCRs. These tools will enable in vivo characterization of myosin-specific CD8 + T cells in murine models of myocardial diseases.
Open AccessIdentification of a novel myosin antigen activating CD8 + T cells in C57BL/6 mice
Summary: Heart-specific T cells play important roles in myocardial diseases, including myocarditis, myocardial infarction, and heart failure. However, only few cardiac antigens and their respective specific T cell receptors (TCRs) have been validated so far. Therefore, we sought to identify new cardiac T cell epitopes in C57BL/6 mice and to characterize the specific TCRs. Antigen mapping of myosin heavy chain alpha (MYHCA) led to the identification of a 9-mer epitope (MYHCA 724-732 ) recognized by CD8 + T cells. Single-cell TCR sequencing (scTCR-seq) analysis of MYHCA-stimulated CD8 + T cells enabled the identification of distinct TCRs enriched on specific T cells. Selected TCRs inferred from scTCR-seq data were then expressed on reporter cell lines and functionally validated. Our study expands the toolkit required to study heart-directed immune responses by revealing a new cardiac antigen and specific TCRs. These tools will enable in vivo characterization of myosin-specific CD8 + T cells in murine models of myocardial diseases.